Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China.
Zhang Y, Zhang M, Jiang Y, Li X, He Y, Zeng P, Guo Z, Chang Y, Luo H, Liu Y, Hao C, Wang H, Zhang G, Zhang L.
Zhang Y, et al. Among authors: zhang l, zhang m, zhang g.
J Cancer Res Clin Oncol. 2018 Nov;144(11):2177-2186. doi: 10.1007/s00432-018-2718-1. Epub 2018 Jul 24.
J Cancer Res Clin Oncol. 2018.
PMID: 30043277
Review.